Private insurers covering people receiving treatment for dialysis paid four times more than government insurance programs such as Medicare paid for the same service. Government programs paid, on average, $248 per dialysis session, compared with $1,041 per session for people with private insurance.
As states crack down on doctor and pharmacy 'shopping' by people who misuse opioids, a new study reveals how often those individuals may still be able to find opioids to misuse in their family medicine cabinets. For every 200 patients prescribed opioids, one had a family member whose opioid-misuse problem led them to seek the drugs from multiple prescribers and multiple pharmacies.
In a new study, George Mason University faculty researchers assessed primary care provider experiences with the CareFirst Patient-Centered Medical Home (PCMH) program. Nurse care coordinators and individual care plans for adults with chronic conditions were key to improving health care delivery.
Hospital costs account for nearly half of all personal health spending for the privately insured, but relatively is known about how much more the privately insured pay hospitals relative to Medicare patients. A new study that examines hospital charges across 25 states in 2017 finds that the prices paid to hospitals for privately insured patients averaged 241% of what Medicare would have paid, with wide variation in prices among states.
A new study finds that hospitalizations for diabetic ketoacidosis rise sharply as adolescents transition to adulthood in the US, but not in Canada. The authors conclude that disruption in health coverage in the US for young adults is the leading factor in the increase in hospitalizations, compared to the universal and seamless coverage of the Canadian system.
Escaping the grip of opioid addiction doesn't come easily for anyone. But a new study reveals sharp racial and financial divides in which Americans receive effective treatments for opioid addiction. Those differences have only grown larger as the national opioid crisis has intensified, the research shows. For every appointment where a person of color received a prescription for the addiction-treatment medication called buprenorphine, white patients had thirty-five such appointments from 2012 to 2015.
This study used national survey data to estimate buprenorphine prescription rates to treat opioid use disorder by race/ethnicity and by payment type for office visits, which is how most patients with buprenorphine prescriptions get care. Researchers report buprenorphine office visits increased from 0.04% to 0.36% of ambulatory visits from 2004-2015 and that represented about 13.4 million visits from 2012-2015.
A study based on a national database of private insurance claims suggests few patients at high risk of opioid overdose receive prescriptions for naloxone, which can reverse an overdose, during encounters with the health care system from hospitalizations and emergency department visits to physician visits.
The amount of money people pay out-of-pocket for drugs to treat neurologic conditions like multiple sclerosis, dementia and Parkinson's disease has risen sharply over 12 years, with the most dramatic increase for multiple sclerosis (MS) medications, according to a study published in the May 1, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Those who were enrolled in both Medicare and Medicaid were sicker, had more cognitive impairments and difficulty functioning, and needed more social support than those who were not enrolled in both government programs, Saint Louis University research found. These patients also had significantly higher healthcare costs.